Stem Cell

Stem Cell

Created using Figma
Created using Figma

Ultimo aggiornamento

16 set 2018

Cellule staminali ICO  Stiamo espandendo la nostra rete con esperti, laboratori, cliniche, ospedali e organizzazioni non profit. Il nostro obiettivo finale è legare le persone che hanno bisogno di cure con le giuste soluzioni professionali ed esperti per le loro esigenze uniche. Alla SCI, come molti altri servizi sono nella società moderna, penso che una tale connessione sia conveniente e dovrebbe essere fatta a portata di mano. Qualunque cosa provenga, possiamo connetterci istantaneamente allo specialista delle cellule staminali attraverso l'applicazione per l'innovazione delle cellule staminali (applicazione SCI), indipendentemente da dove provengano tutti, e quante informazioni confidenziali possono essere scambiate con esperti. Vuoi condividerlo?
Main-Sale
21 nov 2018
17 gen 2019
100% completato
$2 520 000
100% obbiettivo completato
past
  • 1 SCIA
    =
    0.15 USD
Pre-Sale
17 set 2018
9 ott 2018
100% completato
$2 520 000
100% obbiettivo completato
past
Dettagli del token
telescrivente
SCIA
Valute accettate
ETH, LIT, BITC
Dettagli della Compagnia
Paese registrato
Gibraltar
dettagli aggiuntivi
piattaforma
Ethereum
KYC
categorie
piattaforma

Di Stem Cell

Stem Cell Innovations (SCI) è una rete di ricercatori altamente motivati, professionisti medici esperti, investitori dedicati e ingegneri innovativi che lavorano insieme per creare una piattaforma unica che riunisce due delle innovazioni più rivoluzionarie del 21 ° secolo: la tecnologia delle cellule staminali e blockchain te chnology.

Sin dalla sua fondazione iniziale all'inizio del 2013 con il nome Camden RAD, LLC, SCI ha svolto un ruolo cruciale nella ricerca e nello sviluppo delle cellule staminali in tutto il mondo, e abbiamo condotto i nostri casi studio nazionali e internazionali per promuovere la ricerca in questo entusiasmante campo . Le attività della SCI nel campo della scienza delle cellule staminali hanno contribuito direttamente ai progressi nel campo, così come alle nuove scoperte di cellule staminali in tutto il mondo.

Le cellule staminali sono un tipo unico di multicell trovato nel corpo degli esseri umani. Si tratta di una collezione indifferenziata di cellule in grado di fornire innumerevoli applicazioni nello sviluppo di nuove cellule da utilizzare nel trattamento di malattie e condizioni, recupero e ripristino di parti del corpo e, con la nostra ricerca e sviluppo, molte altre applicazioni a venire.

Ad oggi, le aree di studio della SCI hanno incluso le condizioni ortopediche, neurologiche e polmonari, nonché le applicazioni di cellule staminali oncologiche. Sebbene la ricerca condotta dalla SCI abbia fatto passi da gigante in questi settori della medicina, rimane
un'immediata necessità di ulteriori ricerche e sviluppi attraverso un vasto nesso di condizioni mediche che hanno un impatto su milioni di persone in tutto il mondo. In qualità di leader nella ricerca sulle cellule staminali, SCI intende continuare a organizzare e partecipare a molti altri casi studio per aggregare i dati che possono essere utilizzati per avanzare in questo campo innovativo.

Caratteristiche

Attualmente, gli ospedali e le organizzazioni negli Stati Uniti e in tutto il mondo stanno conducendo ricerche sulle cellule staminali per promuovere il campo. ad oggi, la maggior parte dei casi studio rivela risultati positivi. Durante la ricerca clinica al di fuori degli Stati Uniti, le cellule staminali sono state utilizzate con successo come forma di trattamento. Il trattamento e la tecnologia delle cellule staminali continuano ad essere all'avanguardia della ricerca e della scoperta medica e prevediamo che le cellule staminali diventeranno una parte ancora più importante della comunità medica.

Oltre a promuovere la ricerca, SCI progetta di offrire banche staminali attraverso l'ecosistema di applicazioni di cellule staminali. I genitori saranno in grado di ordinare un kit di raccolta, programmare il ritiro del corriere e registrarsi per l'archiviazione delle cellule staminali, tutto attraverso un'unica applicazione sicura. perché SCI offrirà una rete mondiale di opzioni di archiviazione e terapia delle cellule staminali ai propri utenti, è in una posizione unica per semplificare il processo di banca delle cellule staminali per i genitori e ridurre i costi per la raccolta e lo stoccaggio.

SCI ha sviluppato una formula unica che consentirà ai nostri utenti di acquistare un trattamento di cellule staminali sintetiche personalizzato, personalizzato per le loro esigenze mediche. Con il consenso del paziente e le informazioni minime come la data di nascita, il gruppo sanguigno, le allergie, la diagnostica e diverse domande relative alla salute, SCI eseguirà sequenze di laboratorio interne e sicure che sono collegate a un algoritmo proprietario che abbiamo sviluppato. l'algoritmo si traduce nella capacità di strutturare una cellula staminale sintetica progettata su misura per un individuo che necessita di un trattamento specifico. SCI è orgogliosa di questa tecnologia rivoluzionaria e ancora più entusiasta di condividerlo con il mondo. I progressi nella ricerca sulle cellule staminali e l'accessibilità da SCI porteranno il mondo a innovazioni eccezionali per la vita.

& nbsp;

Informazioni tecniche

Protecting confidential user information is vital to the success of a system like the one we are proposing. to ensure security and privacy, Stem Cell Innovations will require users signing into the SCIApplication to provide information and generate a unique identifier within the SCI ecosystem. A unique identifier is an alphanumeric string of information that is assigned to a specific piece of data in an electronic database; in this case, the SCI platform and application. users will be given a unique identifier that will be generated using a proprietary algorithm, which will be used and stored using blockchain technology. the SCI unique identifier will act as users’ keys within the SCI network. through cryptographic methods, the data used to generate the key will be kept secret and secure, able to be parsed only by the SCI decoder. unique identifiers enable access to customized stem cell services and therapies offered throughout the expansive SCI network to our users. SCI will provide personalized stem cell solutions to patients using our platform, and as the SCI network and suite of services grow, users who opt into these services will be apprised of advancements and new treatment options as they become available.

SCI plans to run on dual blockchain platforms. the first platform will be built on an ethereum base for token use only, and it will be powered by the eRC20 platform. the second blockchain will be a custom application designed and built by SCI engineers tailored to fit the healthcare environment.
SCI has decided to build its own blockchain for storing and processing patient stem cell records. this customized blockchain is known as SCIChain. SCIChain will use the Hyperledger fabric network, which will be designed to use smart contracts to protect data and ensure only authorized individuals have access to user data. SCI engineers realize that the Hyperledger fabric blockchain has unique functionalities that differ from other blockchain types that fit with the needs of SCI’s vision and product.

Smart contracts are the gatekeepers of the SCIApplication. users will be free to change their settings at will should their treatments change or preferences change. using mathematical equations equal to the eRC20 platform, SCI ensures user privacy. the straightforward validation associated with a blockchain environment is a secure process that ensures data integrity. furthermore, a cryptography public key will be added to the SCIChain and application to promote a higher standard of security. the symmetric-encrypted key used by SCIChain is 2048-bit, which is a supremely secure method of data transformation in today’s technology-based world.

% name% Roadmap

  • white_paper_v1.1.pdf

  • Please check our whitepaper

Attività

Seguaci:
10 546
VERY HIGH
Piace:
10 447
VERY HIGH
Valutazione:
5
VERY HIGH
Seguaci:
2 770
MEDIUM
tweets:
601
VERY HIGH
Crescita di 30 giorni:
-32
Utenti:
2 681
MEDIUM
Crescita di 30 giorni:
-271

Stem Cell Squadra

verificata 86%

Attenzione. C'è il rischio che i membri non verificati non siano effettivamente membri del team

Moe Galal
Chief Executive Officer / Founder
verificata
Ben Barel
Chief Operations Officer / Co-Founder
verificata
Ali Alrashidi
Chief Technology Officer / Co-Founder
verificata
Matt Galal
Chief of Staff / Co-Founder
verificata
Kobi Barel
Operations Engineer / Co-Founder
verificata
John Glavinovich
Medical Director
verificata
Philip Glukhovsky,
Health Informatics Manager
verificata
Roger Williams
VP of Marketing
verificata
Liz Curlett
VP, PR & Corporate Communications
verificata
Candice Kouchache
Business Development
verificata
Ahmed Elsantawi
VP of International Human Resources
verificata
David Marmon
Web Designer
verificata
Rakel Apodaca
Product Manager
non verificato
Michelle Chavon
Marketing
non verificato

Advisors

verificata 33%

Attenzione. C'è il rischio che i membri non verificati non siano effettivamente membri del team

10 ICOs

$5 540 000

Boyan Josic
Advisor
non verificato

5 ICO

$7 040 000

Marc X. Ellul
Advisor
non verificato
Roger Shortz
Advisor
verificata
Pantea Nakieen
Advisor
non verificato
Shahab Sajadi
Advisor
verificata

2 ICO

$5 040 000

Igor Soshkin
Advisor
non verificato

Stem Cell Interviste

Moe Galal
As a team member, сan you tell us about your role in the ICO project?
Provided clarifications, corrections, and data query resolution with study sites Stem Cell Labs; assisted with quality assurance audits. Developed and reviewed clinical reports, progress/status reports, and final study reports. Build Block-chain to construct the healthcare System, the future of healthcare (Stem Cell) with the future of technology (Block-chain). Form Stem Cell Labs Worldwide.

As the previous founder of Global Medical Management, Inc, founded in 2001, I'm able to tap into my vast network in the medical management community to get the word out about SCI and lends my business expertise to the company in a variety of ways. In order to become the premier provider of stem cell services around the world, myself and the team at SCI continue to collaborate, inspire, and innovate at a time when the medical industry needs not only a face lift, but a complete makeover.
What do you think about idea?
With the better part of 2018 behind us, we look toward what the future holds for SCI and the stem cell community at large. Q4 will see the sale and distribution of the ERC-20 tokens through the Ethereum platform which will drive the continued research and development of stem cell therapies, access, engagement, and treatment around the world. With breakthroughs happening in the stem cell industry on a regular basis, it’s important to pay attention to how this complex, yet soon-to-be-highly-accessible treatment options are changing the world. Much work has yet to be done, but here are just some of the exciting things happening in the stem cell industry at large.

Restoring Heart Function
Regeneration is Made Possible
Creating New Life
Making People Healthy Again

SCI Will Bridge the Gap for Research and Application, idea that never been executed. SCI is working to create research opportunities like these and many others and will connect these innovated treatments to the people who could benefit from them the most with the blockchain-based platform that will provide secure and transparent transactions and interactions to procedures, specialists who can provide such treatments, education, insight, and more. Research and development like what we’ve seen in the first half of 2018 encourages our mission and fuels our vision to bring these life-changing therapies and discoveries to people around the world.
Ben Barel
As a team member, сan you tell us about your role in the ICO project?
healthcare professional with over 20 years of experience managing and overseeing corporate operations, human resources, and compliance reporting in a variety of settings As the Coo, a key member of SCI’s leadership team.
I have taken on a vital leadership role in the building, implementing, and overseeing all of SCI’s corporate operations, processes, workflows and procedures. He plays a critical role in helping to shape and guide the future growth and development of the organization.
What do you think about idea?
This is an amazing project that will

1. bring global awareness for stem cell

2. connect everyone (professional, providers, scientists, and users) around the stem cell.

3. Secure user information on blockchain

4. decentralize stem cell records
Ali Alrashidi
As a team member, сan you tell us about your role in the ICO project?
Chief Technology Officer / Co-Founder
I have a background rich in programming and development, I manages SCI’s blockchain platform. My support in furthering academic research in the field of blockchain will allow SCI to grow.
What do you think about idea?
SCI's platform is "Next Generation" Technology, it's paving the way for advancements in Stem Cell & Healthcare on Blockchain. I'm thrilled to be apart of this journey.
Matt Galal
As a team member, сan you tell us about your role in the ICO project?
Stem Cell Innovations is changing the face of health care by expanding access to stem cell research.
What do you think about idea?
SCI, we are devoted to the international research development & implementation of stem cell therapy.
Kobi Barel
As a team member, сan you tell us about your role in the ICO project?
Responsibilities such as problem solving which includes finding the problem , testing the problem solving and concluding the problem is a daily task as an engineer of operations for companies as innovate radiology Imaging and Stem cell Innovations.
What do you think about idea?
We are bringing two complicated but great tools together to form the best next thing out there for everyone else to follow. I take pride that I am involved in a project that will be used 100 years from now!!
John Glavinovich
As a team member, сan you tell us about your role in the ICO project?
John Glavinovich, M.D. -Medical Director
With over 30 years’ experience in hospital-related clinical, management and operational practices, Dr. Glavinovich a non-traditional approach to the work being done by the team
What do you think about idea?
For the past 20 years I've had an extensive interest in alternative and cutting age medicine. I've worked in recent years on a preventative, proactive and restorative approach to medical treatment including Stem Cell Therapy, The Idea of bringing Stem Cell services to a secure network is important for me and patients alike. I'm excited to see this company reach it's potential and change the way people receive Stem Cell Treatment.
Philip Glukhovsky,
As a team member, сan you tell us about your role in the ICO project?
To consult in proper utilization of stem cell technology and new stem cell research. To maintain a streamlined, patient oriented app interface.
What do you think about idea?
Wonderfully innovative and novel approach that will be the beginnings of the future of modern healthcare.
Roger Williams
As a team member, сan you tell us about your role in the ICO project?
My role at SCI is as their VP of Marketing, I'm known for my innovative approach to marketing and my experience will greatly benefit SCI as the company expands it network and services in the stem cell industry.
What do you think about idea?
Over the years I've worked with many startup companies, whether I believed in the cause or not, but when I heard SCI's platform model, I immediately jumped on board, knowing it was going to change the future for regenerative medicine.
Liz Curlett
As a team member, сan you tell us about your role in the ICO project?
Liz is responsible for strategic development and tactical implementation of media production programs for Stem Cell Innovations. Activities include presentation, video and visual content program oversight, and in-person appearances and speaking engagements when needed. Liz works closely with all members of the SCI team, to create effective and engaging content in order to update stakeholders and build the SCI Brand.
What do you think about idea?
I believe SCI is building an elegant, multi-faceted solution to need that is without boarders. While some countries are still deciding how they want to regulate and/or facilitate stem cell therapy, the market projections and growing demand cannot be ignored. In addition, SCI has selected blockchain technology to address additional marketplace inefficiencies and to ensure this solution remains accessible.

I am thrilled to be part of a team and look forward to contributing my time, resources and experience to the SCI mission.
Candice Kouchache
As a team member, сan you tell us about your role in the ICO project?
I work closely with the SCI team/board to ensure the success of the project, helping to develop internal practices and overall support.
What do you think about idea?
The idea of SCI is innovative and fresh, they have combined two of the worlds smartest inventions, creating an application that will change the way people look at “stem cells” & “Blockchain”
Ahmed Elsantawi
As a team member, сan you tell us about your role in the ICO project?
VP of International Human Resources
15 years’ experience in Human Resources allows the company to ensure the organization grows in a sustainable and efficient way.
What do you think about idea?
Stem Cells on Blockchain
Stem Cell Innovations is changing the face of health care by expanding access to stem cell research, development, and treatments around the world using blockchain technology.
David Marmon
As a team member, сan you tell us about your role in the ICO project?
I am the designer of all the different web / presentation components as well as the developer of the website.
What do you think about idea?
Very, very solid idea. Much needed and revolutionary. Being a part of this team continues to be great.
Roger Shortz
As a team member, сan you tell us about your role in the ICO project?
As an advisor with SCI I bring to the table knowledge as a board certified neurosurgeon with decades of experience. I have advanced training and interest in minimally invasive spinal surgery, as well as complicated spinal instrumentation and fusion.
What do you think about idea?
Stem Cell Innovation is bringing two major issues together to solve the problems we as medical professional have currently. Treatment for with Stem Cells is so "taboo" it is difficult to receive, on the other hand privacy for our patients is threaten daily with the lack of Security with HIPPA. Blockchain technology can change all that. Glad to be of assistance in the process.
Shahab Sajadi
As a team member, сan you tell us about your role in the ICO project?
Adviser in the Pharmaciducal aspect , including a detail data comparison of compounding to stem cell treament.
What do you think about idea?
SCI is bring the future of medicine to the public and i am amazed with what we as a company are doing for the upcoming future.

Stem Cell Ultime novità

N/A
5.0 4
ICO Profilo Visione Attività Potenziale Prodotto Squadra
  • Poiché potrebbero esserci differenze temporali negli aggiornamenti delle informazioni, è necessario verificare le informazioni accurate su ciascun progetto ICO attraverso il suo sito web ufficiale o altri canali di comunicazione.
  • Questa informazione non è un suggerimento o consiglio su come investire in finanziamenti ICO. Si prega di indagare approfonditamente le informazioni rilevanti da soli e decidere sulla partecipazione ICO.
  • Se pensi che ci siano problemi o problemi da correggere su questo contenuto, o se desideri inviare il tuo progetto ICO da elencare, per favore inviaci un'email.
Si prega di leggere la dichiarazione di non responsabilità e l'avviso di rischio. Mostra disclaimer e avviso di rischio.
Planning an ICO? We can help with a wide range of support for all stages of your ICO